Services on Demand
Article
Indicators
Related links
Bookmark
Arquivos de Neuro-Psiquiatria
Print version ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.54 no.3 São Paulo Sept. 1996
http://dx.doi.org/10.1590/S0004-282X1996000300019
Líquido cefalorraquiano no diagnóstico de metástase cérebro-meníngea de melanoma maligno derivado de nevo melanocítico gigante congênito: relato de caso
Cerebral spinal fluid to diagnose CNS metastasis from malignant melanoma arising in a giant congenital melanocytic nevus: case report
José Augusto B. RolimI; Orlando G. R BarsottiniI; Gilmar F. PradoII; Fernando NakandakareII; Maria L. A. A. ReisIII; J. B. Reis-FilhoIV
IMédico-Residente do 3° ano de Neurologia da EPM-UNIFESP
IIMédico Chefe do Plantão do Pronto Socorro de Neurologia da EPM-UNIFESP
IIIBióloga do Setor de LCR da EPM-UNIFESP
IVProfessor-Adjunto, Pesquisador do CNPq e Chefe do Setor de LCR da Disciplina de Neurologia da EPM-UNIFESP
RESUMO
Relatamos o caso de um paciente, de 28 anos, portador de nevo melanocítico gigante congênito(NMGC), com transformação em melanoma e metastátase no sistema nervoso central (SNC). Descrevemos resumidamente as características patológicas de ambas as lesões(NMGC e melanoma), a frequência de malignização do NMGC, os órgãos mais frequentemente acometidos pelas metastases do melanoma - dando ênfase ao acometimento do SNC - além dos fatores que podem levar à malignização do NMGC, os exames usados para o diagnóstico das metástases no SNC - ressaltando a importância do líquido cefalorraquiano - e algumas modalidades terapêuticas para o melanoma com acometimento do SNC.
Palavras-chave: Melanoma maligno, metástase, sistema nervoso central, líquido cefalorraquidiano, nevo melanocítico gigante congênito.
ABSTRACT
We describe the case of a 28-year-old man with a giant congenital melanocytic nevus (GCMN) with malignant transformation to melanoma and metastasis on the central nervous system (CNS). We also make a summary of the pathological features from both lesions(GCMN and melanoma), the occurrence of malignancy of GCMN, the organs more frequently involved with metastatic melanoma - with emphasis to involvement of CNS -just as the factors that cause malignant transformation of GCMN; the methods to diagnose metastases in CNS - emphasizing the importance of cerebrospinal fluid - and some therapeutical modalities for the metastatic melanoma in CNS.
Key words: Melanoma, metastases, central nervous system, cerebrospinal fluid, giant congenital melanocytic nevus.
Texto completo disponível apenas em PDF.
Full text available only in PDF format.
REFERÊNCIAS
1. Aichner F, Schuler G. Primary leptomenigeal melanoma: diagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography. Cancer 1982;50:1751 -1756. [ Links ]
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978;42:660-668. [ Links ]
3. Arnold HL Jr, Odom RB, James WD. Doenças da pele de Andrews. Dermatologia clínica. Ed 8. São Paulo: Manole, 1994:870-890. [ Links ]
4. Caporaso N, Greene MH, Tsai S, Pickle LW, Mulvihill JJ. Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet 1987,24:299-314. [ Links ]
5. Carella RJ, Gebler R, Hendrickson F, Berry HC, Cooper JS. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group, brain metastases study I and II. Cancer 1980;45:679. [ Links ]
6. Castilla EE, Durta MDG, Oriolo-Parreirs IM. Epidemiology of congenital pigmented nevi: incidence rates and relative frequencies. Br J Dermatol 1981;104:407-415. [ Links ]
7. Das Gupta T, Brasfield R. Metastatic melanoma: a clinicopathological study. Cancer 1964; 17:1323-1339. [ Links ]
8. DeVita VT, Hellman S, Rosenberg S A (eds). Cutaneous melanoma in Cancer. Principles and practice of oncology. Philadelphia: Uppincott, 1982:1124-1170. [ Links ]
9. Einhorn LH, Burgess MA, Vallejos C et al. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res 1974,34:1995-2004. [ Links ]
10. Feun LG, Lee YY, Plager C, Papadopoulos N, Savaraj N, Charnsangavej C, Benjamin RS, Wallace S. Intra-carotid cisplatin-based chemotherapy in patients with malignant melanoma and CNS metastases. Am J Clin Oncol 1990; 13:448-451. [ Links ]
11. Fox H. Neurocutaneous melanosis. In Vinken PJ, Bruyn GW (eds). Handbook of clinical neurology. Amsterdam: North Holland, 1972,14:414-428. [ Links ]
12. Gottlieb JA, Frei E, Luce JK. An evaluation of the management of patients with cerebral matastases from malignant melanoma. Cancer 1972;29:701-705. [ Links ]
13. Kadonaga JN, Frieden IJ, Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol 1991;24:747-755. [ Links ]
14. Legha S, Ring S, Plager C. Evaluation of a triple-drug regimen containing cisplatin, vinblastine and DTIC in patients with metastatic melanoma. Proc Am Soc Clin Oncol 1988;7:250. [ Links ]
15. Livramento J A, Machado LR, Clemente HAM, Tabares-Olives A, Spina-França A. Melanomatose meníngea: análise citomorfológica do LCR. Arq Neuropsiquiatr 1979;37:7-14. [ Links ]
16. Madajewics S, Karakousis C, West CR. Malignant melanoma brain metastases: review of the Roswell Park Memorial Institute experience. Cancer 1984;53:2550-2552. [ Links ]
17. McGrady BJ, McCormick DF, Toner PG. Ultrastructural aspects of tumour invasion in the central nervous system. J Pathol 1993;169:89-97. [ Links ]
18. Mitchell MS. Relapse in the central nervous system in melanoma patients sucessfully treated with Biomodulares. J Gin Oncol 1989;7:1701-1709. [ Links ]
19. Mitchell MS, Kan-Mitchell J, Kempf RA. Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 1988;48:5883-5893. [ Links ]
20. Padilla SR, McConnel TS, Gribble JT, Smoot C. Malignant melanoma arising in a giant congenital melanocyte nevus. Cancer 1988;62:2589-2594. [ Links ]
21. Quaba AA, Wallace AF. The incidence of malignant melanoma (0 to 15 years of age) arising in large congenital nevocellular nevi. PlastReconstrSurg 1986;78:174-179. [ Links ]
22. Reed WB, Becker SW Sr, Becker SW Jr et al. Giant pigmented nevi melanoma and leptomeningeal melanocytosis. Arch Dermatol 1965;91:100-119. [ Links ]
23. Reis JB , Bei A, Reis-Filho JB. Líquido cefalorraquiano. São Paulo: Sarvier, 1980. [ Links ]
24. Retsas S, Gershuny AR. Central nervous system involvement in malignant melanoma. Cancer 1988,61:1926-1934. [ Links ]
25. Rey JA, Bellow MJ, de Campos JM, Ramos MC, Benitez J. Cytogenetic findings in a human malignant melanoma metastatic to the brain. Cancer Genet Cytogenet 1985; 16:179-183. [ Links ]
26. Reyes-Mugica M, Chou P, Byrd S, Ray V, Castelli M, Gattuso P, Gonzales-Crussi F. Nevomelanocytic proliferations in the CNS of children. Cancer 1993;71:2277-2285. [ Links ]
27. Rhodes AR, Wood WC, Sober AJ, et. al. Nonepidermal origin of malignant melanoma with giant congenital nevocellular nevus. Plast Reconstr Surg 1981 ;67:782-790. [ Links ]
28. Richmond A, Fine R, Murray D, Lawson DH, Priest JH. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 1986;86:295-302. [ Links ]
29. Sampaio S, Castro R, Rivitti E. Dermatologia básica. Ed3. São Paulo: Artes Médicas, 1989:504-512. [ Links ]
30. Singhal S, Singh K, Fernandes P, Sharma S, Chander S, Rath GK, Bose S. Primary melanoma of the CNS: report of a case and review of the literature. Indian J Cancer 1991 ;28:92-98. [ Links ]
31. Uematsu Y, Yukawa S, Yokote H, Itukura T, Hayashi S, Komai N. Meningeal melanocytoma: magnetic resonance imaging characteristics and pathological features. J Neurosurg 1992;76:705-709. [ Links ]
32. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intra cerebral metastases in solid tumor patients: natural history and results of treatment. Cancer 1981;48:384-394. [ Links ]
Aceite: 19-março-1996.
Estudo realizado no Pronto-Socorro de Neurologia da Disciplina de Neurologia da Escola Paulista de Medicina(EPM) da Universidade Federal de São Paulo(UNIFESP)
Dr. José Augusto Rolim - Disciplina de Neurologia, Escola Paulista de Medicina UNIFESP - Rua Botucatu 740 04023-062 São Paulo SP - Brasil.











